Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). (Q37235840)
Jump to navigation
Jump to search
scientific article published on 16 March 2009
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). |
scientific article published on 16 March 2009 |
Statements
1 reference
Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD). (English)
1 reference
Bernard Zinman
1 reference
John B Buse
1 reference
John Gerich
1 reference
Andrew Lewin
1 reference
Sherwyn Schwartz
1 reference
Philip Raskin
1 reference
Paula M Hale
1 reference
Milan Zdravkovic
1 reference
Lawrence Blonde
1 reference
LEAD-4 Study Investigators
1 reference
16 March 2009
1 reference
1 reference
1224-1230
1 reference
Identifiers
1 reference
1 reference
1 reference